The Dallas-based company says its product incorporates bias-busting algorithms that overcome the lack of diverse populations available for model training.

An AI startup has been cleared to market a platform for precisely mapping prostate cancer with 3D visualization so the tumor can be treated without harm to healthy surrounding prostate tissue.

Big Tech’s recent expansions into medical imaging have business watchers scrambling to decipher the unspoken stratagems beneath the conspicuous moves.

More than half of surveyed radiologists worry about MRI contrast availability, yet almost all—99%—wish for contrast agents that would cut current gadolinium concentrations at least in half.

Last fall Yale Radiology began offering users of its EHR-based patient portal a link to a page on RadiologyInfo.org headed “How to read your radiology report.” The page drew 400 or so clicks in its first two weeks. Today it’s getting 5,000 to 10,000 a month.

Remote radiology is not without its formidable challenges. A longtime veteran of the model discussed a number of these in a session at RSNA 2022.

Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage.

“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022.